My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 100

    2.

    Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenografts.

    Xi Y, Riker A, Shevde-Samant L, Samant R, Morris C, Gavin E, Fodstad O, Ju J.

    Cancer Genomics Proteomics. 2008 Jan-Feb;5(1):1-35.PMID: 18359977 [PubMed - indexed for MEDLINE]Related articles

    3.

    Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients.

    Xu Y, Theobald V, Sung C, DePalma K, Atwater L, Seiger K, Perricone MA, Richards SM.

    J Transl Med. 2008 Oct 22;6:61.PMID: 18945350 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The anti-tumor immune response induced by a combination of MAGE-3/MAGE-n-derived peptides.

    Zhang XM, Zhang YF, Huang Y, Qu P, Ma B, Si SY, Li ZS, Li WX, Li X, Ge W, Hu PZ, Sui YF.

    Oncol Rep. 2008 Jul;20(1):245-52.PMID: 18575744 [PubMed - indexed for MEDLINE]Related articles

    6.

    The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis.

    Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, Shevde LA, Li W, Eschrich S, Daud A, Ju J, Matta J.

    BMC Med Genomics. 2008 Apr 28;1:13.PMID: 18442402 [PubMed]Related articlesFree article

    7.

    [An immunocytochemical investigation of antigen expression by skin melanoma cells cultured for vaccine production]

    Moiseenko VM, Danilova AB, Danilov AO, Turkevich EA, Baldueva IA, Matsko DE.

    Vopr Onkol. 2008;54(3):303-14. Russian. PMID: 18652234 [PubMed - indexed for MEDLINE]Related articles

    8.

    Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients.

    Akiyama Y, Maruyama K, Tai S, Takikawa M, Ohshita C, Yamamoto A, Yamazaki N, Kiyohara Y, Yamaguchi K.

    Int J Oncol. 2008 Sep;33(3):433-41.PMID: 18695871 [PubMed - indexed for MEDLINE]Related articles

    9.

    Current state of vaccine therapies in non-small-cell lung cancer.

    Romero P.

    Clin Lung Cancer. 2008 Feb;9 Suppl 1:S28-36. Review.PMID: 18540532 [PubMed - indexed for MEDLINE]Related articles

    10.

    Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.

    Palucka AK, Ueno H, Connolly J, Kerneis-Norvell F, Blanck JP, Johnston DA, Fay J, Banchereau J.

    J Immunother. 2006 Sep-Oct;29(5):545-57.PMID: 16971810 [PubMed - indexed for MEDLINE]Related articles

    11.

    Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes.

    Bloethner S, Hemminki K, Thirumaran RK, Chen B, Mueller-Berghaus J, Ugurel S, Schadendorf D, Kumar R.

    Melanoma Res. 2006 Aug;16(4):297-307.PMID: 16845325 [PubMed - indexed for MEDLINE]Related articles

    12.

    Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics.

    Zhang JG, Eguchi J, Kruse CA, Gomez GG, Fakhrai H, Schroter S, Ma W, Hoa N, Minev B, Delgado C, Wepsic HT, Okada H, Jadus MR.

    Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):566-75.PMID: 17255279 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    A unified framework for finding differentially expressed genes from microarray experiments.

    Shaik JS, Yeasin M.

    BMC Bioinformatics. 2007 Sep 18;8:347.PMID: 17877806 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Co-expression patterns of tumor-associated antigen genes by non-small cell lung carcinomas: implications for immunotherapy.

    Karanikas V, Tsochas S, Boukas K, Kerenidi T, Nakou M, Dahabreh J, Poularakis T, Gourgoulianis KI, Germenis AE.

    Cancer Biol Ther. 2008 Mar;7(3):345-52. Epub 2007 Dec 13.PMID: 18094614 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Functions of Anti-MAGE T-cells induced in melanoma patients under different vaccination modalities.

    Connerotte T, Van Pel A, Godelaine D, Tartour E, Schuler-Thurner B, Lucas S, Thielemans K, Schuler G, Coulie PG.

    Cancer Res. 2008 May 15;68(10):3931-40.PMID: 18483279 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model.

    Berinstein NL.

    Ann N Y Acad Sci. 2009 Sep;1174:107-17.PMID: 19769743 [PubMed - indexed for MEDLINE]Related articles

    17.

    Establishment of a screening system for chemicals that upregulate a melanoma antigen, Melan-A/MART-1.

    Song HZ, Kono M, Tomita Y.

    Tohoku J Exp Med. 2009 Mar;217(3):231-7.PMID: 19282659 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Expression of melanoma-associated antigens in oral squamous cell carcinoma.

    Ries J, Vairaktaris E, Mollaoglu N, Wiltfang J, Neukam FW, Nkenke E.

    J Oral Pathol Med. 2008 Feb;37(2):88-93.PMID: 18197853 [PubMed - indexed for MEDLINE]Related articles

    19.

    Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients.

    Serana F, Sottini A, Caimi L, Palermo B, Natali PG, Nisticò P, Imberti L.

    J Transl Med. 2009 Mar 24;7:21.PMID: 19317896 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Patient-specific vaccines derived from autologous tumor cell lines as active specific immunotherapy: results of exploratory phase I/II trials in patients with metastatic melanoma.

    Dillman RO, DePriest C, DeLeon C, Barth NM, Schwartzberg LS, Beutel LD, Schiltz PM, Nayak SK.

    Cancer Biother Radiopharm. 2007 Jun;22(3):309-21.PMID: 17651037 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk